Potential for replacing warfarin with a direct oral anticoagulant for endoscopic mucosal resection in the colorectum: A multicenter, open‐label, randomized controlled trial

OBJECTIVES: This study aimed to evaluate the efficacy and safety of apixaban replacement (AR) as an alternative to heparin bridging (HB) in patients taking warfarin and scheduled for endoscopic mucosal resection (EMR) in the colorectum. METHODS: This trial was conducted at seven institutes in Japan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Takuya, Kuwai, Toshio, Sasaki, Yoshihiro, Sakakibara, Yuko, Uraoka, Toshio, Kato, Motohiko, Watanabe, Noriko, Kimura, Toshihisa, Kada, Akiko, Saito, Akiko M., Harada, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302298/
https://www.ncbi.nlm.nih.gov/pubmed/35873512
http://dx.doi.org/10.1002/deo2.102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302298/
https://www.ncbi.nlm.nih.gov/pubmed/35873512
http://dx.doi.org/10.1002/deo2.102

Ejemplares similares